Marc Azémar

638 total citations
15 papers, 492 citations indexed

About

Marc Azémar is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Marc Azémar has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 4 papers in Genetics. Recurrent topics in Marc Azémar's work include Immunotherapy and Immune Responses (4 papers), Acute Myeloid Leukemia Research (2 papers) and Virus-based gene therapy research (2 papers). Marc Azémar is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Acute Myeloid Leukemia Research (2 papers) and Virus-based gene therapy research (2 papers). Marc Azémar collaborates with scholars based in Germany, Switzerland and France. Marc Azémar's co-authors include Clemens Unger, Hans‐Eckart Schaefer, Michael Lübbert, S. Temerinac, Elisabeth Strunck, Heike L. Pahl, W. Lange, Steffen Klippel, Bernd Groner and Gerold Meinhardt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Cancer.

In The Last Decade

Marc Azémar

15 papers receiving 473 citations

Peers

Marc Azémar
Comparison fields: 5 of 59
  • Immunology 170
  • Molecular Biology 155
  • Oncology 150
  • Genetics 142
  • Hematology 107
Replace A. Allart Stoop with:
A. Allart Stoop United Kingdom
M L Banquerigo United States
Julie Parmentier United States
Kanteti V. Prasad United States
Rick D. Holly United States
Rachel L. Morgan United States
J.P. Salier France
JA Hamilton Australia
Taichi Sekine Japan
Alexander Gruze Austria
A. Allart Stoop United Kingdom View profile →
Citations per field, relative to Marc Azémar
Marc Azémar · 1×
Citations per year, relative to Marc Azémar
Marc Azémar · 1×

Countries citing papers authored by Marc Azémar

Since Specialization
Citations

This map shows the geographic impact of Marc Azémar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Azémar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Azémar more than expected).

Fields of papers citing papers by Marc Azémar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Azémar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Azémar. The network helps show where Marc Azémar may publish in the future.

Co-authorship network of co-authors of Marc Azémar

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Azémar. A scholar is included among the top collaborators of Marc Azémar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Azémar. Marc Azémar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Work Indexed citations
1 5
2 3
3 43
4 31
5
Tumour Biology: tumour-associated inflammation versus antitumor immunity.
25
6 3
7
IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.
7
8 30
9
Cytotoxic efficacy and influence on cellular phospholipid metabolism of 2-hydroxy- and 2-O-acetyl-octadecylphosphocholines.
1
10 13
11 69
12 1
13 86
14 164
15 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026